Thomas Foster

Founding Partner

Mr. Foster is a 30 year veteran of the life sciences, healthcare, technology and other IP-based industries. He has supported over 500 client organizations, and his career has focused on characterizing both value and risk. He has been a pioneer in developing valuation techniques for assets without relevant market analogs. He is expert in decision-support frameworks that translate uncertainty into quantifiable risk.

Mr. Foster‘s work provides independent and objective strategic advisory services that include market characterization, valuation, transaction support and financial opinions.

Additionally, Mr. Foster has deep experience as a pricing and access professional. At one time, he had supported the pricing strategies for 7 of the 10 best selling global life sciences products.

Past Professional History

• Foster Rosenblatt: Managing Partner

• RNA Advisors: Advisory Board

• IQVIA (IMS Health) Consulting: Vice President

• Cambridge Pharma Consultancy: Senior VP, Strategy

• PAREXEL International: Practice Leader, Benchmarking

• Helix Research: Chief Operating Officer

• Princeton Alternative Investments: Financial Analyst

Thought Leadership

Mr. Foster is a frequent author and speaker on various issues with contributions to articles appearing in Bloomberg, The New York Times, The Economist, Wall Street Journal, Time, Reuters & other publications. Additionally, he has been a Scholar at the Massachusetts Institute of Technology (MIT), a Lecturer at the Columbia School of Business and the Darden School of Business University of Virginia. He was the Editor of the PAREXEL Statistical Sourcebook.

Awards

• Lifetime Achievement Award: Pharmaceutical Management Science Association

• President’s Award: IQVIA (IMS Health)

Mr. Foster has a BA from Brown University.